ALMKT:EPA
Mauna Kea Technologies SA
0,092 €
0,00%
(0,00) 1 d
13 nov., 17:35:01 GMT+1 · EUR
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för ALMKT …
Öppen
0,09 €
Högt
0,10 €
Lågt
0,09 €
Börsvärde
18,14 mn
Genomsn. vol.
541,14 tn
Volym
75,16 tn
P/E-tal
0,79
52v högst
0,23 €
52v lägst
0,07 €
EPS
0,12 €
Utestående aktier
195,26 mn
Antal anställda
56
Öppen
0,09 €
Högt
0,10 €
Lågt
0,09 €
Börsvärde
18,14 mn
Genomsn. vol.
541,14 tn
Volym
75,16 tn
P/E-tal
0,79
52v högst
0,23 €
52v lägst
0,07 €
EPS
0,12 €
Utestående aktier
195,26 mn
Antal anställda
56
Nyheter och artiklar
Från webbkällor och nyhetspartner
TradingView
·
för 1 timme sedan
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
TradingView
·
för 1 timme sedan
SpaceX's S&P 500 bid gets new life as Elon Musk pitches Tesla merger
The Motley Fool
·
för 2 timmar sedan
Warren Buffett's Berkshire Compounded at More Than 19% a Year Over Six Decades, Nearly Double the S&P 500's 10% Return. Can Investors Still Apply That Playbook Today?
Traders Union
·
för 1 timme sedan
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Om Mauna Kea Technologies SA
VdSacha Loiseau
Anställda56
Grundades2000
Huvudkontor-
SektorHealth Care
Bransch-
Webbplatsmaunakeatech.com